# Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

> **NCT00364468** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 107 (actual)

## Conditions studied

- Neutropenia

## Interventions

- **DRUG:** pegfilgrastim

## Key facts

- **NCT ID:** NCT00364468
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00364468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00364468, "Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00364468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*